Ratcliffe, Man Utd. likely to reveal £1.3B deal - Breaking The News

Ratcliffe, Man Utd. likely to reveal £1.3B deal

4 December

1 min read

UNSPLASH / JAVID_NADERI

Sir Jim Ratcliffe and Manchester United Football Club are poised to reveal an agreement in which the billionaire would acquire 25% of the club's shares in a £1.3 billion arrangement "early next week," Sky News reported on Monday, citing people familiar with the matter.

As per the sources, there is a possibility that the timetable might change, but both United and Ratcliffe's INEOS Group Limited anticipate making the announcement next week. The media outlet added that neither Ratcliffe nor Sir Dave Brailsford, the former cycling authority in charge of INEOS's sporting operations, are expected to join the club's public company board.

Previously, the same news outlet disclosed that discussions were underway regarding a $33-per-share deal.

mergers and acquisitions ineos ratcliffe manchester united football

Musk's xAI acquires social media platform X

28 March

Billionaire entrepreneur Elon Musk announced on Friday that X.AI Corp. (doing business as xAI) acquired the social media platform X in an all-stock transaction."xAI and X’s futures are intertwined. Today, we officially take the step to combine the data, models, compute, distribution and talent. This combination will unlock immense potential by blending xAI’s advanced AI capability and expertise with X’s massive reach. The combined company will...

Repsol UK to form new unit with NEO Energy

27 March

Spanish petrochemical company Repsol S.A. announced on Thursday that its British business will combine with NEO Energy Group's North Sea arm to form Neo Next Energy. The resulting unit will be managed by a joint team, with NEO owning 55% and Repsol 45%."This combination will create a jointly governed business which will call upon the key strengths of both shareholders," Repsol Exploration and Production Executive Managing Director Francisco Gea said....

Merck to buy Hengrui Pharma's drug for up to $1.8B

25 March

Merck & Co. Inc. said on Tuesday that it entered into an exclusive license agreement with Jiangsu Hengrui Pharmaceuticals Co. Ltd. for a cardiovascular disease drug HRS-5346, currently in a phase 2 trial in China. Merck will pay $200 million upfront and commit to milestone payments of up to $1.8 billion, as well as royalties on net sales.The drug is an investigational oral small molecule inhibitor of lipoprotein(a) formation (lp(a)). "Elevated blood concentrations of...

Apollo takes 25% stake in BP Pipelines for $1B

21 March

BP plc announced on Friday that Apollo Funds will buy a non-controlling 25% stake in its pipelines business for around $1 billion. The transaction is expected to close in the second quarter of 2025. BP Pipelines owns a 12% interest in the Trans-Anatolian gas pipeline (TANAP), which carries natural gas from Azerbaijan across Turkey.BP said the funds will go toward its plan for $20 billion in divestment and other proceeds. "This [deal] unlocks capital from our...

This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.